This approach has been employed to produce exosomes that express SIRPα and blockCD47-SIRPα interactions between tumor cells and T lymphocytes,55 and to generate exosomes expressing the EGFR-specificpeptide GE11 to promote their interaction with EGFR-positive breast cancer cells.57 The gene discussed is SIRPA; the disease is breast carcinoma.